Loading patent…
OwnerFrancis E. O'Donnell, Jr., Robert M. Nalbandian +1inventors
InventorsFrancis E. O'Donnell, Jr., Robert M. Nalbandian, Eberhard Mammen
Estimating the term…
An intraocular lens for implanting in the posterior chamber of a human eye after an extracapsular extraction, the intraocular lens having adhesive means applied to its backside thereof, said adhesive means being applied either an annulus, around the outer perimeter of backside of the lens, or entirely over the backside of the lens, when implanted against the posterior wall, and has a tendency to effect tissue growth between said posterior wall and the adhesive means for effectively retaining the implanted intraocular lens in place; the adhesive means comprising either a biological glue, formed either as fibrin, comprised of an annular patch, or as a collagen, formed as an annular patch, or as a fibrin containing as an additive ingredient collagen particles, or being impregnated with lyophilized fibronectin, or the adhesive means may comprise a biological glue in the form of mussel glue, for adherence against the backside of the lens, either around its circumferential perimeter, or over the entire backside of the lens, during IOL implanting, or the adhesive means may comprise a nonbiological glue, or said adhesive means may comprise a combination of either a biological and nonbiological glue for adherence of the IOL in place after implanting.
An intraocular lens (IOL) capable of implanting in the posterior chamber of a human eye and against its posterior wall after an extracapsular extraction, said IOL having an adhesive means applied to its backside thereof, such that said adhesive means creates a continuous peripheral barrier against the central migration of lens epithelium along the posterior capsule from which it attains support, and said IOL being adapted to be positioned within the chamber and to be sealed against said a posterior wall of the eye by means of said adhesive means.
An intraocular lens for implanting in the posterior chamber of a human eye after an extracapsular extraction, said lens having a backside, said intraocular lens having a biological adhesive applied to its backside as a continuous peripheral barrier, said biological adhesive being capable of interacting with the patient's own coagulation system, such that the connective tissue formed between said posterior wall and the biological adhesive permanently anchoring the said lens to its adjacent posterior wall.
An intraocular lens for implanting in the posterior chamber of a human eye after an extracapsular extraction, wherein said intraocular lens having an adhesive applied thereto, a first adhesive applied to the outer circumference of the backside of the lens, and a different adhesive applied centrally to the backside thereof, and with said combined adhesives providing for adherence of the IOL to the posterior wall and thereby permanently anchoring of the said lens within the posterior capsule.
An IOL, for implant within the human eye after extracapsular extraction, wherein said IOL is for positioning within the posterior capsule of the eye by means of a nontoxic, nonabsorbable, nonbiological glue, and wherein said glue being applied to at least a continuous peripheral portion of the back of the IOL just prior to its implanting.
An intraocular lens for implanting in the posterior chamber of a human eye after an extracapsular extraction, wherein said intraocular lens having an adhesive means applied thereto, said adhesive means being applied to the backside of the lens, said adhesive means being applied to the entire outer circumference of the backside of said lens, and with said adhesive providing for adherence of the intraocular lens to a posterior wall of any human eye and thereby permanently anchoring of the said lens within the eye's posterior capsule.
Dependencies are inferred from the claim text.